![Jeffrey Bloss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Bloss
Technik-/Wissenschafts-/F&E-Leiter bei
NUCANA PLC
Vermögen: 12 255 $ am 31.03.2024
Profil
Jeffrey D.
Bloss is currently Director at National Pharmaceutical Council since 2016, Senior Vice President-Medical & Scientific Affairs at Astellas US LLC since 2012, and Chief Medical Officer at NuCana Plc since 2021.
Former positions include Chief Medical Officer at Tarveda Therapeutics, Inc. from 2018 to 2021, Chief Medical Officer & Senior VP-Medical Affairs at Aegerion Pharmaceuticals Ltd. (United Kingdom) from 2017 to 2018, Group Medical Director at Genentech, Inc., Oncology Director at Eli Lilly & Co., Director-Clinical Research & Compliance Office at the University of Missouri in 2013, Vice President-Clinical Development at Onyx Pharmaceuticals, Inc., Chief Medical Officer at Xencor, Inc., and Principal at United States Air Force Medical Corp.
Education includes a doctorate from Thomas Jefferson University and an undergraduate degree from Juniata College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUCANA PLC 0,15 % | 18.03.2026 | 47 136 ( 0,15 % ) | 12 255 $ | 31.03.2024 |
Aktive Positionen von Jeffrey Bloss
| Unternehmen | Position | Beginn |
|---|---|---|
| NUCANA PLC | Technik-/Wissenschafts-/F&E-Leiter | 10.08.2021 |
Astellas US LLC
 Astellas US LLC Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2012 |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Direktor/Vorstandsmitglied | 04.11.2016 |
Ehemalige bekannte Positionen von Jeffrey Bloss
| Unternehmen | Position | Ende |
|---|---|---|
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2021 |
Aegerion Pharmaceuticals Ltd. (United Kingdom)
 Aegerion Pharmaceuticals Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2018 |
United States Air Force Medical Corp. | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Technik-/Wissenschafts-/F&E-Leiter | - |
University of Missouri
 University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Jeffrey Bloss
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
44
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
University of Missouri
University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juniata College
 Juniata College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Pharmaceutical Council
National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Commercial Services |
Astellas US LLC
Astellas US LLC Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
United States Air Force Medical Corp. | |
NuCana Plc
 NuCana Plc BiotechnologyHealth Technology Develops and commercializes novel anti-cancer medicines | Health Technology |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
Aegerion Pharmaceuticals Ltd. (United Kingdom)
Aegerion Pharmaceuticals Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
